Collegium Pharma (COLL) Tops Q3 EPS by 29c
Tweet
Share
E-mailGet Alerts COLL Hot Sheet
Join SI Premium – FREE
Collegium Pharma (NASDAQ: COLL) reported Q3 EPS of ($0.45), $0.29 better than the analyst estimate of ($0.74).
For earnings history and earnings-related data on Collegium Pharma (COLL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- HP Inc. projects mid-single-digit PC market decline in 2027
- RBC Capital Reiterates Sector Perform Rating on ExxonMobil (XOM)
- Citi lowers East West Bancorp price target to $152
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
